Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Popular Supplements Don't Work Against Arthritis: Study

But lead researcher says it's too soon to give up on glucosamine

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Abdominoplasty
Acidophilus
Alzheimer's Disease
Animal Bites
More...

Related Healthscout Videos
 border=
Nutrition and Cancer
Nutrition and Osteoporosis
Importance of Good Nutrition
Nature’s Remedies
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Erectile Dysfunction
Osteoarthritis
Rheumatoid Arthritis
More...

Related Drug Information
 border=
Actonel
Coumadin
Detrol LA
Ditropan XL
More...

Related News Articles
 border=
Substitutions Make Holiday Fare Healthier
High Blood Pressure Stalks Many Americans
Health Tip: Signs of Celiac Disease in Children
Aquarobics May Help Ease Labor
More...

TUESDAY, Sept. 30 (HealthDay News) -- The popular supplements glucosamine and chondroitin are no better than a placebo at preventing cartilage loss in knees of people with the form of arthritis caused by wear and tear, a new study found.

Still, the researcher who led the study said glucosamine may help some people with osteoarthritis.

Text Continues Below



The researcher, Dr. Allen D. Sawitzke, an associate professor of internal medicine at the University of Utah School of Medicine, also acknowledged that the trial wasn't conclusive because of the small number of participants and the relatively short duration -- two years.

Sawitzke said that what struck him as possibly significant was the lower rate of joint loss for participants taking only glucosamine -- 0.013 millimeters, about one-tenth as much as found in those taking either other supplements or a placebo.

"That is not statistically significant, but it hints to me that there might be something going on," he said.

"It was a null study that didn't show a difference," Sawitzke admitted, before adding: "That's not the same as saying there is no difference. The result was influenced by the slow rate of progression for everybody. The study actually says more about what we need to do for the next investigation than for what patients should do."

The new findings, published in the October issue of the journal Arthritis & Rheumatism,, was a continuation of the earlier Glucosamine/chondroitin Arthritis Intervention Trial (GAIT), led by University of Utah researchers.

Arthritis sufferers take glucosamine either to reduce pain or to slow progression of the condition, Sawitzke said. "Controls pain -- this study says nothing about it," he said. "Slows progression -- the study says we weren't able to show that."

For the new study, GAIT participants were given the chance to continue their original study treatment for an additional 18 months, for a total of two years -- 500 milligrams of glucosamine three times a day; 400 milligrams of chondroitin sulfate three times a day; or a combination of the two supplements; 200 milligrams of the pain killer celecoxib (Celebrex) daily; or a placebo.

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 9/30/2008

Related Links
 border=
From Healthscout's partner site on osteoarthritis, MyOsteoarthritisCentral.com
Understanding osteoarthritis symptoms and arthiritis pain
Learn about osteoarthritis treatments
How to avoid osteoarthritis with exercise





SOURCES: Allen D. Sawitzke, M.D., associate professor of medicine, University of Utah School of Medicine, Salt Lake City; Andrew Shao, vice president for science and regulatory affairs, Council for Responsible Nutrition, Washington, D.C.; October 2008, Arthritis & Rheumatism


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service